| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 198.270 | 257.454 | 322.658 | 397.340 | 285.148 | 237.229 | 322.563 | 393.637 | 433.711 | 476.914 |
| Total Income - EUR | 199.430 | 257.771 | 323.745 | 399.003 | 287.616 | 239.679 | 322.593 | 393.637 | 434.664 | 482.614 |
| Total Expenses - EUR | 191.703 | 224.717 | 311.456 | 359.194 | 252.535 | 202.237 | 232.586 | 297.312 | 353.122 | 405.706 |
| Gross Profit/Loss - EUR | 7.726 | 33.054 | 12.289 | 39.809 | 35.082 | 37.441 | 90.007 | 96.324 | 81.542 | 76.908 |
| Net Profit/Loss - EUR | 5.923 | 27.457 | 7.860 | 35.819 | 32.206 | 35.238 | 87.426 | 92.451 | 77.195 | 62.429 |
| Employees | 4 | 5 | 6 | 10 | 7 | 4 | 4 | 6 | 7 | 6 |
Check the financial reports for the company - Homeodent Art Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 49.612 | 40.798 | 79.448 | 69.223 | 56.306 | 46.830 | 33.772 | 27.019 | 37.711 | 56.851 |
| Current Assets | 16.183 | 28.565 | 34.394 | 56.821 | 83.707 | 118.159 | 129.853 | 76.496 | 52.800 | 53.619 |
| Inventories | 1.200 | 7.633 | 19.158 | 8.722 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10.351 | 7.570 | 5.290 | 4.775 | 4.531 | 6.099 | 6.036 | 6.055 | 35.149 | 19.296 |
| Cash | 4.632 | 13.362 | 9.946 | 43.324 | 79.176 | 112.060 | 123.817 | 70.441 | 17.651 | 34.323 |
| Shareholders Funds | 27.155 | 27.511 | 34.905 | 70.083 | 100.932 | 134.257 | 87.475 | 92.500 | 77.790 | 62.478 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.575 | 43.728 | 80.808 | 57.847 | 41.054 | 32.706 | 78.216 | 13.203 | 15.146 | 48.398 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.010 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Homeodent Art Srl